Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, Oxford University Hospitals NHS Foundation Trust and the Patient experience healthcare company Oneview Healthcare signed a research and development (R&D) agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot.

Image courtesy of Medical Sciences Division and John Cairns

Oneview Healthcare PLC (Oneview) have announced a partnership with The Chancellor Masters and Scholars of the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) to continue research and development on a clinical pathways product. The solution will ease administrative burden, digitise currently paper-based processes and ultimately expedite wait times and access to care.

In conjunction with a leading engineering company, University of Oxford, OUH and Oneview entered into a partnership in an agreement dated 31 January 2017 to pilot a digital pathways for prostate cancer to improve patient outcomes and deliver cost efficiencies to health systems. That pilot’s success is the catalyst for the new agreement. The prostate cancer pilot succeeded in the areas of clinical staff uptake, meeting or exceeding wait time goals, and providing an easy-to-use interface the clinicians embraced. The new research and development will focus on expanding the technology to include full commercial deployment at Oxford via a SMART on FHIR1 integration and expansion of scope to other types of  cancer (beyond prostate cancer). The partners expect to commercialise the new products globally, helping healthcare organisations around the world to digitise care pathways, connecting information across systems to drive clinical transformation and reduce variation.

Professor Freddie Hamdy, Head of Oxford University's Nuffield Department of Surgical Sciences and Divisional Director of Surgery and Oncology at OUH, commented: 'This is one of the most innovative projects Oxford have done in the past few years.'

James Fitter, CEO of Oneview Healthcare stated: 'This has been a textbook case of agile development with our team working side-by-side with the Oxford clinicians to solve real-world problems. Combining Oxford’s clinical expertise with our software innovation and integration skills has proved a powerful combination. We are delighted with the results of the pilot and the opportunity to move forward in developing other life-changing cancer pathways. We take pride in our partnership with Oxford University and OUH, and are honoured that we can all work together to advance technology that has so much potential to changes lives around the world.'

1 SMART on FHIR is an open standards-based platform for medical apps designed to promote interoperability

Press release courtsey of Oneview.

Similar stories

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Two NDS researchers receive prestigious MRC Clinical Research Training Fellowships

Miss Catherine Lovegrove and Dr Alexander Sagar from the Nuffield Department of Surgical Sciences (NDS) have been awarded highly competitive Clinical Research Training Fellowships by the Medical Research Council (MRC).

WHO Classification of Tumours programme awarded large grant to improve classification and evidence base

A new project titled Mapping the Evidence for the World Health Organization (WHO) Classification of Tumours: A Living Evidence Gap Map by Tumour Type (WCT EVI MAP), led by researchers of the WHO Classification of Tumours programme at the International Agency for Research on Cancer (IARC), has received a grant of €3.5 million from the European Commission. This four-year project, which will be undertaken in collaboration with six other international institutions, including Oxford University's Nuffield Department of Surgical Sciences (NDS), was launched on 1 July 2022.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.